|
End-of-day quote
Nasdaq Stockholm
|
||
| - SEK | - |
|
| 16-07-20 | Meda : Mylan gets EU approval for Meda purchase, subject to conditions | RE |
| 16-07-15 | Exclusive - Mylan to get EU green light for Swedish drugmaker deal: sources | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 52 | - | |
Mårten Österlund
LAW | General Counsel | 69 | 2014-12-08 |
Rainer Weiss
CTO | Chief Tech/Sci/R&D Officer | 64 | 2004-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 53 | 2016-08-24 | |
| Director/Board Member | 58 | 2016-08-24 | |
| Chairman | 52 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.65% | -2.93% | +47.70% | +86.30% | 994B | |
| -0.29% | -3.51% | +49.15% | +61.95% | 640B | |
| +0.83% | +0.26% | +17.76% | +70.10% | 454B | |
| -0.38% | -3.59% | +30.13% | +34.14% | 337B | |
| -0.09% | -13.54% | +13.34% | +24.74% | 261B | |
| -0.43% | -2.48% | -0.73% | +10.64% | 246B | |
| -1.34% | -13.70% | +36.53% | +46.70% | 204B | |
| -3.44% | -7.51% | -20.63% | -58.97% | 190B | |
| -0.75% | -4.82% | +25.46% | +85.90% | 178B | |
| Average | -0.73% | -5.76% | +22.08% | +40.17% | 389.42B | |
| Weighted average by Cap. | -0.51% | -4.42% | +30.96% | +54.65% |
- Stock Market
- Stocks
- Stock
Select your edition
All financial news and data tailored to specific country editions
